New Key Statistics Module, Z-Score and F-Score
NYSE:RCUS Key Ratios
| Market Cap $ M | 1,448.63 |
| Enterprise Value $ M | 424.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.56 |
| Price/Sales | 5.20 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 263.00 |
| EPS (TTM) $ | -3.15 |
| Beneish M-Score | -2.85 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.59 |
| EV-to-EBITDA | -1.63 |
| PEG | -- |
| Shares Outstanding M | 91.51 |
| Net Margin (%) | -102.66 |
| Operating Margin % | -113.31 |
| Pre-tax Margin (%) | -102.28 |
| Quick Ratio | 5.24 |
| Current Ratio | 5.24 |
| ROA % (ttm) | -22.44 |
| ROE % (ttm) | -46.73 |
| ROIC % (ttm) | -88.34 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.48 |
RCUS Number of Guru Trades
RCUS Volume of Guru Trades
Gurus Latest Trades with NYSE:RCUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RCUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcus Biosciences Inc Insider Transactions
No Available Data
News about NYSE:RCUS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers